Pfizer Inc. is drawing on lessons learned years ago from rolling out Viagra as it maps out the launch of its first obesity ...
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is a key ...
Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo DSP. This expansion of Netflix’s programmatic offerings couldn’t come at a ...
Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Starting today, the program provides ...
Novo Nordisk’s CEO dared Pfizer to bid more if it wanted obesity drug developer Metsera so badly. So Pfizer did, with a $10 billion bid that edges out what the Danish pharmaceutical giant was willing ...
Clinical Trials Arena on MSN
Second Pfizer Braftovi regimen shows benefit in mCRC
This recent readout follows successful data from another combination including Braftovi in mCRC.
The stock gained 10.35% to hit intraday highs of ₹5,257, continuing its gaining streak from Monday, when it closed 3.79% ...
Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and more Affirms Pfizer’s commitment to reduce drug costs for millions of Americans ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results